Media-OutReach Newswire Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Media-OutReach Newswire VinBrain welcomes new board and advisory board members, Dr. Gregory Moore, and Jonathan T. Fried